See also this year's filing and all EDGAR filings for this company.
PDF Report 0001560241_2023_G1_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001560241, G1 Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 179,500,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,989,000 |
| 3 | remainder_Assets | 6,476,000 |
| 4 | LiabilitiesCurrent | 35,588,000 |
| 5 | LiabilitiesNoncurrent | 5,615,000 |
| 6 | remainder_Liabilities | 78,015,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 100,415,000 |
| 9 | ResearchAndDevelopmentExpense | 83,316,000 |
| 10 | remainder_Expenses | 5,448,000 |
| 11 | remainder_Revenues | 51,301,000 |
| 12 | remainder_NetIncome | -9,681,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 187,965,000 |
| 1 | Liabilities | 119,218,000 |
| 2 | Expenses | 189,179,000 |
| 3 | Revenues | 51,301,000 |
| 4 | StockholdersEquity | 68,747,000 |
| 5 | NetIncome | -147,559,000 |
| 6 | ComprehensiveNetIncome | -147,559,000 |
| 7 | BaseVar | 278,672,000 |
| 8 | EconomicCapitalRatio | -0.191 |
Edgar->Model Mapping
Feature Distribution
Change over Time
